Breeding for Better Solventless Extraction with Alisha Holloway, PhD

Ben Amirault June 3, 2026Cultivation, Podcast

Alisha Holloway is the Chief Scientific Officer at Phylos where she leads the R&D group that focuses on foundational genomic research, development of high-throughput genetic and chemical testing capabilities, discovery of genetic markers, and the development of new cannabis varieties via classical and marker-assisted breeding. At CannMed 26, she will present “Enhancing Cannabis Quality via Marker-Assisted Selection for Improved Solventless …

Optimizing Temperature for Butane Extraction with Manny Sosa

Ben Amirault March 25, 2026Cultivation, Podcast, Safety

Manuel Sosa leads the analytical testing and research team at Abstrax Tech. In his role, Manny uses advanced techniques such as Comprehensive two-dimensional gas chromatography and HPLC to conduct rigorous tests and refine Abstrax SOPs to improve precision and efficiency. At CannMed 26, Manny will present “Temperature-Controlled Butane Extraction Minimizes Waxes While Preserving Cannabinoids and VOCs”, which explores how temperature …

Safety and Legality of Delta-8 THC with Greg Gerdeman, PhD

Ben Amirault May 19, 2021Podcast

Greg Gerdeman, PhD is a neuroscientist and educator with expertise in the physiological actions of cannabis and the endocannabinoid system. Recently, Greg has gotten involved in the conversation around Delta-8 THC. He comes at the topic from a neuroscientist’s perspective questioning how much we know about how Delta-8 THC affects the body and the brain. He also raises important questions …

Extracting Cannabis Compounds with Markus Roggen, PhD

Ben Amirault March 10, 2021Podcast

We discuss the chemistry of cannabis with Markus Roggen, PhD. In his various roles and positions, Dr. Roggen oversaw multiple teams that are focused on the whole processing flow of cannabis production, from harvest and drying, through processing and extraction, all the way to the formulation and quality control/analytics. In addition to cannabinoids, Dr. Roggen’s company, Complex Biotech Discovery Ventures …